Richard Rychlik Email

Corporate Controller . ArmaGen

Current Roles

Employees:
6
Revenue:
$930k
About
ArmaGen, Inc., is a privately held biotechnology company focused on developing groundbreaking therapies for severe neurological disorders. The company is developing a robust pipeline of innovative therapies for the treatment of lysosomal storage disorders including neurological symptoms such as Hurler syndrome (MPS I), Hunter syndrome (MPS II), metachromatic leukodystrophy, Sanfilippo A and B syndromes, as well as other diseases with severe CNS manifestations. ArmaGen’s pipeline is based on decades of scientific leadership in engineering therapies to cross the blood-brain barrier and a dominant intellectual property portfolio. The company is advancing its pipeline through licensing and collaboration agreements, in-house development programs, and other partnering opportunities. For more information, visit www.armagen.com.
ArmaGen Address
26679 Agoura Road Suite 100
Calabasas, CA
United States
ArmaGen Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.